Marex Group’s ACM Research ACMR Stock Holding History

Marex Group’s Portfolio ACMR Stock Details ACMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,869	Closed	-$425K	–	966
2025 Q3	$425K	Buy	+10,869	New	+$323K	﹤0.01%	538
2024 Q3	–	Sell	-15,570	Closed	-$359K	–	619
2024 Q2	$359K	Buy	15,570 +15	+0.1%	+$380	0.01%	372
2024 Q1	$453K	Buy	+15,555	New	+$356K	0.01%	263
2023 Q1	–	Sell	-100,000	Closed	-$758K	–	257
2022 Q4	$758K	Buy	+100,000	New	+$847K	0.11%	135

Other funds holding ACMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Marex Group's ACMR Position: Q4 2025 in Review

Marex Group sold out of ACM Research (ACMR) in Q4 2025, closing a stake of 10,869 shares — an estimated $425K sold.

Marex Group first reported a position in ACMR in Q4 2022 and held it in 4 quarters. The position peaked at $758K in Q4 2022. 277 funds tracked by Wall St. Rank hold ACMR as of Q4 2025.

Marex Group reported no remaining ACM Research position as of Q4 2025 after selling out during the quarter.
Marex Group sold 10,869 ACM Research shares in Q4 2025, an estimated $425K.
Marex Group first reported a position in ACM Research in Q4 2022 and held it in 4 quarters.
Marex Group's ACM Research position peaked at $758K in Q4 2022.
277 funds tracked by Wall St. Rank held ACM Research as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.